Recent Updates
Recently added Catalysts
COLL Positive Sentiment

Collegium to Report Second Quarter 2024 Financial Results on August 8, 2024

Thursday, July 25, 2024 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Collegium Pharmaceutical, Inc. has announced that it will report its second quarter 2024 financial results on August 8, 2024, after market closure. Following the financial announcement, a live conference call will take place at 4:30 p.m. ET, which will also be available for replay. The company emphasizes its commitment to enhancing lives of those with serious medical conditions.
Price reaction · baseline $34.36 (2024-07-24 close) · hit after-hours · 1 other COLL headline(s) in the window, move may be shared
day 0 close · peak
+3.1%

Market Sentiment Analysis

POSITIVE FACTORS

  • Collegium Pharmaceutical will report its second quarter financial results.
  • The company is committed to improving the lives of people with serious medical conditions.
  • A live conference call will be hosted for investors.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+28%
120-day peak, hindsight
Typical move
0.4%
average across 3 past catalysts
Lead asset
DFN-15 Active
Phase 3 · Migraine Headache

Full Press Release Details

STOUGHTON, Mass., July 25, 2024 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions, today announced that it will report second quarter 2024 financial results after the market closes on Thursday, August 8, 2024. Following the release of the financials, the Company will host a live conference call and webcast at 4:30 p.m. ET.
Conference Call Information
To access the conference call, please dial (877) 407-8037 (U.S.) or (201) 689-8037 (International) and reference the “Collegium Pharmaceutical Q2 2024 Earnings Call.” An audio webcast will be accessible from the Investors section of the Company’s website: www.collegiumpharma.com. The webcast will be available for replay on the Company’s website approximately two hours after the event.
About Collegium Pharmaceutical, Inc.
Collegium is a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions. Collegium’s headquarters are located in Stoughton, Massachusetts. For more information, please visit the Company’s website at www.collegiumpharma.com.
Christopher James, M.D.

Frequently Asked Questions

When will Collegium report Q2 2024 financial results?

Collegium will report Q2 2024 financial results on August 8, 2024.

How can I access the Collegium conference call?

Dial (877) 407-8037 for the U.S. or (201) 689-8037 internationally.

What time is the Q2 2024 earnings call scheduled?

The earnings call will start at 4:30 p.m. ET on August 8, 2024.

Where is Collegium Pharmaceutical headquartered?

Collegium Pharmaceutical is headquartered in Stoughton, Massachusetts.

Will there be a replay of the earnings webcast?

Yes, the webcast will be available for replay two hours after the event.

ShareAdd on Google
Tags: COLL Viatris Investor Conferences Healthcare Collegium Pharmaceutical second quarter financial results earnings call
Last updated: Jul 25, 2024

Biotech snapshot

Cash runway
$150M liquidity · $0M/mo burn
Low dilution risk
Lead asset
DFN-15 ActivePhase 3
Migraine Headache →

Catalyst track record

+28%
best trade around COLL's most recent catalyst

Peak hindsight return over a 120-day window, across 3 tracked FDA/PDUFA catalysts for COLL.

See every catalyst's timing & PoA →